Dolby Laboratories, Inc. (NYSE:DLB – Free Report) – Equities research analysts at Barrington Research lowered their Q3 2025 earnings per share (EPS) estimates for shares of Dolby Laboratories in a research note issued to investors on Wednesday, November 20th. Barrington Research analyst J. Goss now anticipates that the electronics maker will post earnings of $0.50 per share for the quarter, down from their prior estimate of $0.52. Barrington Research has a “Outperform” rating and a $100.00 price objective on the stock. The consensus estimate for Dolby Laboratories’ current full-year earnings is $2.67 per share.
A number of other research firms have also commented on DLB. StockNews.com raised Dolby Laboratories from a “buy” rating to a “strong-buy” rating in a research report on Monday, November 18th. Rosenblatt Securities increased their target price on shares of Dolby Laboratories from $98.00 to $100.00 and gave the company a “buy” rating in a report on Wednesday, November 20th.
Dolby Laboratories Stock Down 0.3 %
DLB stock opened at $80.33 on Monday. The firm has a market capitalization of $7.66 billion, a PE ratio of 29.64 and a beta of 0.98. Dolby Laboratories has a twelve month low of $66.35 and a twelve month high of $90.06. The stock’s 50 day moving average is $74.50 and its 200-day moving average is $75.96.
Hedge Funds Weigh In On Dolby Laboratories
Several institutional investors and hedge funds have recently bought and sold shares of the company. First Affirmative Financial Network lifted its position in shares of Dolby Laboratories by 4.9% during the 2nd quarter. First Affirmative Financial Network now owns 2,766 shares of the electronics maker’s stock valued at $219,000 after buying an additional 129 shares during the last quarter. LRI Investments LLC raised its stake in Dolby Laboratories by 6.0% in the 2nd quarter. LRI Investments LLC now owns 2,293 shares of the electronics maker’s stock valued at $182,000 after acquiring an additional 130 shares during the period. First Horizon Advisors Inc. lifted its holdings in Dolby Laboratories by 22.7% during the third quarter. First Horizon Advisors Inc. now owns 790 shares of the electronics maker’s stock valued at $60,000 after purchasing an additional 146 shares during the last quarter. Signaturefd LLC boosted its position in Dolby Laboratories by 5.1% during the second quarter. Signaturefd LLC now owns 3,167 shares of the electronics maker’s stock worth $251,000 after purchasing an additional 153 shares during the period. Finally, Mitchell & Pahl Private Wealth LLC increased its stake in shares of Dolby Laboratories by 1.3% in the second quarter. Mitchell & Pahl Private Wealth LLC now owns 13,817 shares of the electronics maker’s stock worth $1,095,000 after purchasing an additional 174 shares in the last quarter. 58.56% of the stock is owned by institutional investors.
Insider Activity at Dolby Laboratories
In other Dolby Laboratories news, Director Peter C. Gotcher sold 6,079 shares of the business’s stock in a transaction dated Thursday, November 21st. The shares were sold at an average price of $78.96, for a total value of $479,997.84. Following the transaction, the director now directly owns 37,593 shares in the company, valued at $2,968,343.28. The trade was a 13.92 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Kevin J. Yeaman sold 28,512 shares of the firm’s stock in a transaction that occurred on Tuesday, October 15th. The stock was sold at an average price of $74.12, for a total transaction of $2,113,309.44. Following the sale, the chief executive officer now owns 83,721 shares of the company’s stock, valued at approximately $6,205,400.52. The trade was a 25.40 % decrease in their position. The disclosure for this sale can be found here. 39.54% of the stock is currently owned by company insiders.
Dolby Laboratories announced that its Board of Directors has approved a share buyback plan on Wednesday, August 7th that allows the company to buyback $350.00 million in outstanding shares. This buyback authorization allows the electronics maker to purchase up to 5% of its stock through open market purchases. Stock buyback plans are generally a sign that the company’s management believes its stock is undervalued.
Dolby Laboratories Increases Dividend
The firm also recently announced a quarterly dividend, which will be paid on Tuesday, December 10th. Stockholders of record on Tuesday, December 3rd will be issued a $0.33 dividend. The ex-dividend date of this dividend is Tuesday, December 3rd. This is a positive change from Dolby Laboratories’s previous quarterly dividend of $0.30. This represents a $1.32 annualized dividend and a dividend yield of 1.64%. Dolby Laboratories’s dividend payout ratio is currently 48.71%.
About Dolby Laboratories
Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.
Read More
- Five stocks we like better than Dolby Laboratories
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- Abacus Life’s CEO on Cracking the Code of Longevity Returns
- 3 Stocks to Consider Buying in October
- Elon Musk and Trump Push for Self-Driving Cars: 3 Stocks to Gain
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- Discover the 3 Best Performing Stocks That Went Public in 2024
Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.